Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.

Fuhrmann S, Schabath R, Möricke A, Zimmermann M, Kunz JB, Kulozik AE, Ludwig WD, Schrappe M, Karawajew L, Ratei R.

Br J Haematol. 2018 Oct;183(1):96-103. doi: 10.1111/bjh.15503. Epub 2018 Jul 20.

PMID:
30028023
2.

Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.

Singh A, Schabath R, Ratei R, Stroux A, Klemke CD, Nebe T, Flörcken A, van Lessen A, Anagnostopoulos I, Dörken B, Ludwig WD, Pezzutto A, Westermann J.

Hematol Oncol. 2014 Mar;32(1):16-21. doi: 10.1002/hon.2080. Epub 2013 Jun 24.

PMID:
23798351
3.

Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.

Ratei R, Schabath R, Karawajew L, Zimmermann M, Möricke A, Schrappe M, Ludwig WD.

Klin Padiatr. 2013 May;225 Suppl 1:S34-9. doi: 10.1055/s-0033-1337961. Epub 2013 May 22.

PMID:
23700065
4.

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.

Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, Lacombe F, Lemez P, Marinov I, Matutes E, Maynadié M, Oelschlagel U, Orfao A, Schabath R, Solenthaler M, Tschurtschenthaler G, Vladareanu AM, Zini G, Faure GC, Porwit A.

Leukemia. 2011 Apr;25(4):567-74. doi: 10.1038/leu.2010.312. Epub 2011 Jan 21. Review.

PMID:
21252983
5.

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.

Matutes E, Pickl WF, Van't Veer M, Morilla R, Swansbury J, Strobl H, Attarbaschi A, Hopfinger G, Ashley S, Bene MC, Porwit A, Orfao A, Lemez P, Schabath R, Ludwig WD.

Blood. 2011 Mar 17;117(11):3163-71. doi: 10.1182/blood-2010-10-314682. Epub 2011 Jan 12.

PMID:
21228332
6.

Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.

Lemez P, Attarbaschi A, Béné MC, Bertrand Y, Castoldi G, Forestier E, Garand R, Haas OA, Kagialis-Girard S, Ludwig WD, Matutes E, Mejstríková E, Pages MP, Pickl W, Porwit A, Orfao A, Schabath R, Starý J, Strobl H, Talmant P, van't Veer MB, Zemanová Z; European Group for the Immunological Characterization of Leukemias (EGIL).

Eur J Haematol. 2010 Oct;85(4):300-8. doi: 10.1111/j.1600-0609.2010.01493.x.

PMID:
20561032
7.

Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations.

Gerr H, Zimmermann M, Schrappe M, Dworzak M, Ludwig WD, Bradtke J, Moericke A, Schabath R, Creutzig U, Reinhardt D.

Br J Haematol. 2010 Apr;149(1):84-92. doi: 10.1111/j.1365-2141.2009.08058.x. Epub 2010 Jan 18.

PMID:
20085575
8.

Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias.

Ratei R, Karawajew L, Schabath R, Ehrfeldt A, Grunert F, Ludwig WD.

Int J Hematol. 2008 Mar;87(2):137-143. doi: 10.1007/s12185-008-0044-0. Epub 2008 Feb 27.

PMID:
18299959
9.

SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26.

Hildebrandt M, Schabath R.

Front Biosci. 2008 Jan 1;13:1774-9. Review.

PMID:
17981666
10.

The prognostic significance of antigen expression in leukaemia.

Schabath R, Ratei R, Ludwig WD.

Best Pract Res Clin Haematol. 2003 Dec;16(4):613-28. Review.

PMID:
14592646
11.

The murine chemokine receptor CXCR4 is tightly regulated during T cell development and activation.

Schabath R, Müller G, Schubel A, Kremmer E, Lipp M, Förster R.

J Leukoc Biol. 1999 Dec;66(6):996-1004.

PMID:
10614783

Supplemental Content

Loading ...
Support Center